Article

Cancer Heath Disparities: Moving From Why They Occur to How They Can Be Prevented (vol 30, pg 354, 2012)

College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
Journal of Clinical Oncology (Impact Factor: 18.43). 12/2011; 30(4):354-6. DOI: 10.1200/JCO.2011.39.5947
Source: PubMed
0 Followers
 · 
28 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The efficacy of adjuvant therapy after the resection of pancreatic adenocarcinoma has been demonstrated by several randomized studies. Postoperative treatment applied either as chemotherapy alone or in combination with chemoradiotherapy is therefore considered a recommended standard in resectable pancreatic cancer (PC). Multiple arguments speak in favor of preoperative systemic therapy. Specifically, the conception of PC as a metastatic disease even at the early stage of apparent resectability supports the strategy of upfront systemic therapy. Unfortunately, randomized studies comparing neoadjuvant with adjuvant regimens have not been performed, and the superiority of one strategy over the other still has to be confirmed. Future clinical research may even combine neoadjuvant and adjuvant treatment. New avenues of individualized treatment may also be reached by the inclusion of molecular parameters of the tumor and pharmacogenomic profiles of the patient into decision making.
    Annals of Oncology 09/2012; 23 Suppl 10:x141-x147. DOI:10.1093/annonc/mds312 · 6.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To present an updated review of the incidence, risk factors, staging, diagnosis, and treatment of colon, rectal, and anal cancers, as well as nursing care associated with managing patients diagnosed with these malignancies. Published research reports, epidemiologic data, published patient management guidelines, and institution-based clinical tools. While significant advances in the management of colon, rectal, and anal cancers in the past decade have extended patient survival, there remain some unanswered questions. Further clinical and molecular research will help individualize patient care, refining current therapeutic strategies and treatment decision-making aids while minimizing symptoms of disease and treatment. Nurses need to be familiar with risk factors, disease course, and current and emerging therapies to assist patients with treatment decision-making, and to anticipate and intervene in managing disease and treatment-induced problems. Early identification and management of distressing symptoms can help to avoid life-threatening effects and promote patient adherence to prescribed therapies; timely patient/family education may minimize anxiety and promote self-management.
    Seminars in Oncology Nursing 11/2012; 28(4):e1-e22. DOI:10.1016/j.soncn.2012.09.012
  • [Show abstract] [Hide abstract]
    ABSTRACT: An interactive audio and video telemedicine feasibility program was established to provide counseling on breast cancer risk-reducing strategies for underserved, high-risk Alaskan native women through a collaboration among the Alaska Native Medical Center, the Mayo Clinic Breast Clinic, Mayo's Center for Innovation, and the Alaska Federal Health Care Access Network. The telemedicine model included a navigator to facilitate patient encounters (referrals, electronic records, and scheduling) and a subscription billing contract. Between January 1 and December 31, 2011, 60 consultations were provided to the Alaska Native Medical Center. A survey of a sample of 15 women demonstrated overall patient satisfaction of 98% pertaining to the experience, technology, and medical consultation. The referring physician satisfaction, from 11 visit surveys and 8 referring physicians, revealed 99% satisfaction with the service. In this telemedicine pilot study, we demonstrated the feasibility of a telemedicine program to provide integrated specialty care that resulted in a positive effect on patient satisfaction. This program has a sustainable business model, thus creating a new modality for health care delivery.
    Mayo Clinic Proceedings 01/2013; 88(1):68-73. DOI:10.1016/j.mayocp.2012.10.015 · 5.81 Impact Factor
Show more

Preview

Download
0 Downloads
Available from